Question
stringlengths 13
1.05k
⌀ | Answer
stringlengths 2
801
⌀ |
---|---|
What is the name of the guidance that A’s issued for Medical Device Manufacturers?
|
General Principles of Software Validation
|
What are the majority of class I devices exempt from?
|
the premarket submission requirements
|
What is the FDA's classification of devices?
|
Some FDA classifi
|
What does a 510(k) exempt mean?
|
the manufacturer is not required to submit a premarket notification (i.e., a 510(k)) prior to marketing the device
|
What is the webpage that contains additional information about 510(k) exempt devices?
|
“Medical Device Exemptions 510(k) and GMP Requirements”
|
What is the process for determining whether a reader’s interpretation corresponds to the truth status established during the truthing process?
|
rationale, definition, and criteria
|
What is my app considered?
|
a mobile medical app
|
What are apps from a device manufacturer that provide information to support the company’s own device?
|
mobile medical apps
|
What is not considered on its own to be a device software?
|
Software used for data collection in clinical studies
|
What is the name of the FDA guidance document that contains Nonbinding Recommendations function?
|
FDA’s guidance related to use of computers
|
What is the name of the study that was issued on September 17, 2013?
|
Electronic Source Data in Clinical Investigations
|
What does ANSI stand for?
|
American National Standards Institute
|
What is the ISO 9001 Quality management system?
|
Requirements
|
What is the IEEE Standard for System, Software, and Hardware Verification and Validation?
|
IEEE Std 1012
|
What is the name of the Part 1 of the Guidance on the application of ISO 14971 to medical device software?
|
IEC/TR 80002-1
|
What is the part of the IEC 61508-2 that describes the Functional safety of electrical/electronic/programmable electronic safety-related systems?
|
Part 2: Requirements for electrical/electronic/programmable electronic safety-related systems
|
What should you describe and fix before initiating your evaluation?
|
the scoring process
|
What is the name of the division that provides education about CDRH-regulated devices?
|
Division of Industry and Consumer Education (DICE)
|
What is the address of the Dockets Management Staff, Food and Drug Administration?
|
5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852
|
What is the address of the OCOD?
|
10903 New Hampshire Ave., WO71, Room 3128, Silver Spring, MD 20903
|
What is the address for De Novo Requests?
|
Address
|
What act was passed in 1995?
|
Paperwork Reduction Act of 1995
|
What is the purpose of this document?
|
to provide guidance on the process for the submission and review of a De Novo classification request
|
What does the De Novo classification process provide a pathway to?
|
class I or class II classification
|
What does CBER stand for?
|
Biologics Evaluation and Research
|
What is a device classified in class III and subject to premarket approval?
|
class III
|
What is the risk of a new type of device?
|
the device and the inability of general and special controls to provide reasonable assurance of the safety and effectiveness of the device
|
What is the physical overlap of the boundary, area, or volume of a reader mark in relation to the boundary, area, or volume of reference standard?
|
physical overlap
|
What is the level of risk they pose or the ability of general and special controls to assure safety and effectiveness?
|
level of risk
|
What was the process created by section 513(f)(2) of the FD&C Act referred to as in FDAMA?
|
Evaluation of Automatic Class III Designation
|
What had to be found in order to submit a De Novo request?
|
not substantiated
|
What is a premarket notification?
|
510(k)
|
What did FDA reclassify devices under?
|
section 513(e) of the FD&C Act
|
What is the name of the nonbinding recommendations currently available informatio?
|
Nonbinding Recommendations
|
What is the name of the subpart that FDA will use to assess whether a request for an evaluation of automatic class III designation is granted?
|
21 CFR Part 860, Subpart D--De Novo Classification
|
What is the name of the new section that FDA is updating to reflect the De Novo final rule?
|
513(f)(2) – Evaluation of Automatic Class III Designation, Guidance for Industry and CDRH Staff
|
What must the FDA make a classification determination for?
|
the de: FDA must make a classification determination for the de: FDA must make a classification determination for the de: FDA must make a classification determination for the de: FDA must make a classification determination for the de: FDA must make a classification determination for the de: FDA must make a classification determination for the de: FDA must make a classification determination for the de: FDA must describe the device and detailed information and reasons for any recommended classification
|
What is the subject of the De Novo request by written order within 120 days of receipt of the request?
|
the subject of the De Novo request
|
What should you describe when multiple readers are involved in scoring?
|
the number of readers involved, their qualifications, their levels of experience and expertise
|
What is the device in class III and may not be marketed unless the device i i?
|
the device i
|
What is the definition of a De Novo request?
|
a new De Novo request
|
What will FDA consider a De Novo request for?
|
devices that have already undergone 510(k) review
|
What should appear to meet the statutory standards for classification into class I or class II under section 513(a)(1) of the FD&C Act?
|
general controls or general and special controls would provide reasonable assurance of the safety and e
|
What allows FDA to provide feedback on whether a device may be eligible for the De Novo classification process?
|
A Pre-Sub
|
What is the purpose of a Pre-Sub?
|
to obtain feedback on the evidence, including non-clinical and/or clinical data, that will likely be necessary to support the De Novo request
|
What is a Pre-Sub?
|
A Pre-Sub
|
What will be handled in accordan?
|
De Novo Pre-Subs
|
What does the FDA search to establish that no legally marketed device and no classification regulation for the same device type exists?
|
public databases
|
What should clinical readers learn about the CADe device?
|
a description of the device and instructions for how to use the device
|
What should the Pre- Sub include in order for us to consider the specific questions?
|
Specific questions regarding review issues relevant to a planned De Novo request
|
What type of evidence do you anticipate providing in your De Novo request?
|
valid scientific evidence
|
What is the proposed mitigation measure(s)/control(s) for each risk based on?
|
the best available information at the time of the submission
|
What is the special use of a device?
|
mitigations
|
What are there other risks, in addition to those identified in the Pre-Sub?
|
identified in the Pre-Sub
|
What would be appropriate if additional biocompatibility and/or sterility testing were needed?
|
additional biocompatibility and/or sterility testing
|
What is the name of the document that describes meetings with FDA staff?
|
Q-Sub Guidance
|
What is the De Novo review process outlined in?
|
Attachment 1
|
What is the name of the website that provides information on vaccines and bloodbiologics?
|
CBER
|
What is the required content for a De Novo request?
|
21 CFR 860.220
|
What do you justify in your reading instructions?
|
clinical relevance
|
What is the eCopy program for Medical Device Submissions?
|
eCopy Program for Medical Device Submissions
|
What is the current mailing address for De Novo Requests?
|
current mailing address
|
What is the NSE of a device?
|
general controls or general and special controls may provide reasonable assurance of safety and effectiveness
|
What does the inclusion of this language within an NSE letter indicate?
|
given the risk profile of the device, it seems reasonable that De Novo classification may be appropriate
|
What is the criteria for whether a De Novo request should be reviewed?
|
11
|
What happens if your De Novo request is not accepted for review?
|
the review clock stops and we will notify you that it is on hold pending receipt of additional information
|
What is the deadline for FDA to complete the acceptance review?
|
15 days
|
What is the purpose of the De Novo classification process?
|
to analyze whether a likely predicate device exists or your device falls under a class III classification regulation
|
What will FDA inform you of in your De Novo request, including each applicable ground for declining the De Novo request?
| null |
What is the purpose of an AI letter?
|
If the De Novo request is missing information and/or data necessary to determine whether general controls or general and special controls can provide reasonable assurance of safety and effectiveness
|
What does reader training help avoid?
|
incorrect or un-interpretable results
|
What will resume once you provide a complete response?
|
review
|
What is the reason a De Novo request may be declined?
|
lack of performance data
|
What is the name of the section that allows a De Novo request to be granted?
|
section 515 of the FD&C Act
|
What is the classification of class II devices?
|
special controls
|
What is the result of the final order in the Federal Register providing public notice of the decision?
|
codification of the device’s identification, classification, and applicable requirements in Title 21 of the Code of Federal Regulations
|
What is the name of the website that we intend to make the summary of our review available on?
|
CDRH website
|
What will be redacted to protect any confidential commercial, trade secret, or personal privacy information in accordance with 21 CFR Part 20.?
| null |
What may the submitter of the declined De Novo request do?
|
leverage all information in the De Novo request by incorporating it by reference in a new 510(k) submission
|
What is the FDA's guidance on De Novo Classification Requests?
|
FDA and Industry Actions on De Novo Classification Requests: Effect on FDA Review Clock and Goals
|
What is the OMB subject to review?
|
Paperwork Reduction Act of 1995
|
What is the name of the FDA Office responsible for this guidance?
|
Office responsible for this guidance as listed on the title page
|
What is permissible for an efficient and less burdensome representative case data set?
|
Enrichment with diseased/abnormal cases
|
What is the FDA's responsibility to the public regarding information collection?
|
complete and review the information collection
|
What is the current expiration date?
|
0910-0844
|
What is the minimum amount of FDA calendar days to Grant/ Decline FDA Substantive Review Additional information (AI)?
|
120 FDA calendar days
|
When was the document issued?
|
September 27, 2023
|
What is the name of the U.S. Department of Health and Human Services Office of Communication, Outreach, and Development (OCOD)?
|
OCOD
|
Where can you find the FDA docket number?
|
5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852
|
What is the name of the office that provides the Gui00001825?
|
Office of Communication, Outreach, and Development
|
What is the name of the document that is used to manage cybersecurity risks?
|
SPDF
|
What is the name of the organization that manages the TPLC Security Risk Management?
|
19 B. Security Architecture
|
What is the name of the appendix that contains the Security Control Categories and Associated Recommendations?
|
Appendix 1
|
What will introduce biases into the study design?
|
stress testing
|
What is the name of the document that is used to submit a Security Architecture Flows submission?
|
Submission Documentation for Security Architecture Flows
|
What does not establish any rights for any person and is not binding on FDA or the public?
|
It does not establish any rights for any person and is not binding on FDA or the public
|
What is the need for robust cybersecurity controls to ensure?
|
medical device safety and effectiveness
|
What may lead to patient harm as a result of clinical hazards?
|
cyber attacks and exploits
|
What does ensuring device safety and effectiveness include?
|
adequate device cybersecurity
|
What is the name of the organization that reviews Regulatory Submissions?
|
Center for Biologics Evaluation and Research
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.